文献速递间质性肺疾病

MUC1胞内生物活化介导肺纤维化

MUC1 intracellular bioactivation mediates lung fibrosis.
PubMed 文献 · Thorax · 2019-12-04

该研究在IPF患者(n=22)与健康对照(n=21)中观察到MUC1胞内结构域Thr41和Tyr46磷酸化增强,定位于成纤维细胞和增生的肺泡II型细胞。TGF-β1通过磷酸化SMAD3促进MUC1-CT磷酸化,激活β-catenin形成核复合物,驱动上皮-间质转化、细胞衰老和成纤维细胞增殖。抑制MUC1-CT核转位或敲除MUC1可减轻博来霉素诱导的小鼠肺纤维化。

要点

  • IPF患者MUC1-CT Thr41和Tyr46磷酸化水平升高,定位于成纤维细胞和增生肺泡II型细胞。
  • TGF-β1经SMAD3促进MUC1-CT磷酸化,激活β-catenin形成核复合物驱动纤维化过程。
  • 抑制MUC1-CT核转位或敲除MUC1可减轻博来霉素诱导的小鼠肺纤维化。

核心结论

  • MUC1胞内生物活化在IPF中增强,促进纤维化过程,可能成为IPF的潜在可成药靶点。

研究设计与样本

  • 比较IPF患者(n=22)与健康受试者(n=21)的MUC1表达与磷酸化。
  • 在肺成纤维细胞和肺泡II型细胞中研究TGF-β1信号通路。
  • 使用GO-201抑制剂或siRNA沉默MUC1进行体外干预。
  • 在博来霉素诱导的小鼠肺纤维化模型中评估GO-201和MUC1敲除的效果。

主要发现

  • IPF患者MUC1-CT Thr41和Tyr46磷酸化较健康受试者增加,定位于成纤维细胞和增生肺泡II型细胞。
  • TGF-β1磷酸化SMAD3,增加肺成纤维细胞和肺泡II型细胞中MUC1-CT Thr41和Tyr46磷酸化。
  • 磷酸化SMAD3/MUC1-CT和MUC1-CT/β-catenin形成核复合物,促进肺泡上皮II型及成纤维细胞向肌成纤维细胞转化、细胞衰老和成纤维细胞增殖。
  • GO-201抑制MUC1-CT核转位或siRNA沉默MUC1,减少体外肌成纤维细胞转化、衰老和增殖。
  • GO-201治疗和MUC1敲除小鼠中博来霉素诱导的肺纤维化减轻;galectin-3直接激活MUC1-CT并桥接TGF-β受体与MUC1-C结构域。

临床怎么用

  • MUC1胞内生物活化可作为IPF潜在治疗靶点,抑制MUC1-CT核转位或沉默MUC1在临床前模型中减轻肺纤维化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Serum KL6/mucin 1 (MUC1) has been identified as a potential biomarker in idiopathic pulmonary fibrosis (IPF), but the role of MUC1 intracellular bioactivation in IPF is unknown. OBJECTIVE: To characterise MUC1 intracellular bioactivation in IPF. METHODS AND RESULTS: The expression and phosphorylation of Thr41 and Tyr46 on the intracellular MUC1-cytoplasmic tail (CT) was increased in patients with IPF (n=22) compared with healthy subjects (n=21) and localised to fibroblasts and hyperplastic alveolar type II cells. Transforming growth factor (TGF)-β1 phosphorylated SMAD3 and thereby increased the phosphorylation of MUC1-CT Thr41 and Tyr46 in lung fibroblasts and alveolar type II cells, activating β-catenin to form a phospho-Smad3/MUC1-CT and MUC1-CT/β-catenin nuclear complex. This nuclear complex promoted alveolar epithelial type II and fibroblast to myofibroblast transitions, as well as cell senescence and fibroblast proliferation. The inhibition of MUC1-CT nuclear translocation using the inhibitor, GO-201 or silencing MUC1 by siRNA, reduced myofibroblast transition, senescence and proliferation in vitro. Bleomycin-induced lung fibrosis was reduced in mice treated with GO-201 and in MUC1-knockout mice. The profibrotic lectin, galectin-3, directly activated MUC1-CT and served as a bridge between the TGF-β receptor and the MUC1-C domain, indicating TGF-β1-dependent and TGF-β1-independent intracellular bioactivation of MUC1. CONCLUSIONS: MUC1 intracellular bioactivation is enhanced in IPF and promotes fibrotic processes that could represent potential druggable targets for IPF.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Milara J, Ballester B, Montero P, et al. MUC1 intracellular bioactivation mediates lung fibrosis. Thorax. 2019. PMID: 31801904. doi:10.1136/thoraxjnl-2018-212735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。